Daniel C. Sufficool
YOU?
Author Swipe
View article: Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions
Proton stereotactic body radiation therapy for liver metastases—results of 5-year experience for 81 hepatic lesions Open
Proton SBRT for the treatment of liver metastases has promising LC rates with the ability to safely treat multiple liver metastases. Accrual continues for our phase II trial treating liver metastases with Proton SBRT to 60 GyE (Gray equiva…
View article: Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases
Real world outcomes of combination and timing of immunotherapy with radiotherapy for melanoma with brain metastases Open
Introduction Immunotherapy (IT) and radiotherapy (RT) have improved overall survival in patients with melanoma with brain metastasis (MBM). We examined the real‐world survival impact of IT and RT combination and timing strategies. Material…
View article: A phase I trial of Proton stereotactic body radiation therapy for liver metastases
A phase I trial of Proton stereotactic body radiation therapy for liver metastases Open
Biologically ablative Proton SBRT doses are well tolerated in patients with limited liver metastases with no patients experiencing any grade 2+ acute toxicity. Results from this trial provide the grounds for an ongoing phase II Proton SBRT…